Patents Intellectual Property Strategy

Protecting innovation. Building the future.
NOSTER’s intellectual property strategy is founded on a single commitment:
to ensure that discoveries made through research are translated into value for society.
Since our earliest days as a research-driven company, we have consistently built an intellectual property portfolio that protects discoveries in life science and enables their global application.

Our Intellectual Property Strategy

  1. Prioritizing Composition-of-Matter PatentsGut microbial metabolites remain a largely unexplored scientific frontier.
    Protecting novel compounds themselves provides the strongest foundation for long-term innovation.

  2. Protecting Innovation Through Use and Manufacturing PatentsWhere composition-of-matter protection is not available, we secure intellectual property through
    patents covering therapeutic applications, manufacturing processes, and related technologies.

  3. Building a Global Intellectual Property PortfolioWe pursue international patent protection across Japan, the United States, Europe, and China,
    establishing a competitive intellectual property portfolio spanning drug discovery, functional
    ingredients,
    and analytical technologies.

The HYA Patent Portfolio

HYA (10-hydroxy-cis-12-octadecenoic acid) is a gut microbial metabolite derived from linoleic acid, discovered through collaborative research with Kyoto University.
Today, this discovery has evolved into a broad patent portfolio.

Representative patent categories include:

  • Metabolism improving agent comprising rare fatty acids

  • Intestinal tract-protecting agent containing hydroxy fatty acids

  • Anti-inflammatory agent containing rare fatty acids

  • Novel triglycerides and use thereof

  • 10-hydroxy-cis-12-ocatadecenoic acid alkyl esters and use thereof

  • Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivative

  • Hydroxylated fatty acid homopolymer and production method thereof

  • Intestinal regulating agent (Patent Pending)

  • Muscle atrophy inhibitor (Patent Pending)

Intellectual Property as a Foundation for the Future

For NOSTER, intellectual property is more than legal protection.

  • It safeguards future drug candidates.

  • It protects scientific inventions and their applications.

  • It supports international collaborations.

  • It provides a foundation for the next generation of biotechnology.

Intellectual property is the foundation upon which NOSTER builds the future.